| Literature DB >> 19725581 |
Lisa Dalla Via1, Sebastiano Marciani Magno, Ornella Gia, Anna Maria Marini, Federico Da Settimo, Silvia Salerno, Concettina La Motta, Francesca Simorini, Sabrina Taliani, Antonio Lavecchia, Carmen Di Giovanni, Giuseppe Brancato, Vincenzo Barone, Ettore Novellino.
Abstract
Novel benzo[3',2':5,6]thiopyrano[3,2-b]indol-10(11H)-ones 1a-v were synthesized and evaluated for their antiproliferative activity in an in vitro assay of human tumor cell lines (HL-60 and HeLa). Compounds 1e-v, substituted at the 11-position with a basic side chain, showed a significant ability to inhibit cell growth with IC(50) values in the low micromolar range. Linear dichroism measurements showed that all 11-dialkylaminoalkyl substituted derivatives 1e-v behave as DNA-intercalating agents. Fluorimetric titrations demonstrated their specificity in binding to A-T rich regions, and molecular modeling studies were performed on the most active derivatives (1e, 1i, 1p) to characterize in detail the complexation mechanism of these benzothiopyranoindoles to DNA. A relaxation assay evidenced a dose-dependent inhibition of topoisomerase II activity that appeared in accordance with the antiproliferative capacity. Finally, for the most cytotoxic derivative, 1e, a topoisomerase II poisoning effect was also demonstrated, along with a weak inhibition of topoisomerase I-mediated relaxation.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19725581 DOI: 10.1021/jm900627v
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446